Pantozisaph is a modified-release capsule containing a combination of Pantoprazole (40mg) and Domperidone (30mg). Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, while Domperidone is a prokinetic agent that helps improve gastric motility and relieves symptoms of nausea and vomiting. This combination is commonly used to treat conditions such as gastroesophageal reflux disease (GERD), acid reflux, and other digestive issues like delayed gastric emptying. The modified-release formulation ensures effective, sustained release of the active ingredients over time. This pack contains 30 capsules, typically taken under medical supervision.